The structural basis for agonist and partial agonist action on a β<sub>1</sub>-adrenergic receptor
Tony Warne(MRC Laboratory of Molecular Biology), Christopher G. Tate(MRC Laboratory of Molecular Biology), Rony Nehmé(Lebanese University), Jillian G. Baker(Nottingham University Hospitals NHS Trust), Andrew GW Leslie, R. Moukhametzianov(MRC Laboratory of Molecular Biology), Gebhard F.X. Schertler, Patricia C. Edwards
DORA PSI (Paul Scherrer Institute)
January 1, 2011
Cited by 0
Related Papers
Structure of a β1-adrenergic G-protein-coupled receptor
|Nature|2008|1.3k
The structural basis for agonist and partial agonist action on a β1-adrenergic receptor
|Nature|2011|623
The selectivity of β‐adrenoceptor agonists at human β<sub>1</sub>‐, β<sub>2</sub>‐ and β<sub>3</sub>‐adrenoceptors
|British Journal of Pharmacology|2010|586
The selectivity of <i>β</i>‐adrenoceptor antagonists at the human <i>β</i>1, <i>β</i>2 and <i>β</i>3 adrenoceptors
|British Journal of Pharmacology|2005|535
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390